Suchergebnisse - Vaknin‐Dembinsky, Adi
- Treffer 1 - 20 von 24
- Zur nächsten Seite
-
1
COVID-19 in Cladribine-treated patient with multiple sclerosis von Haham, Nitsan, Vaknin-Dembinsky, Adi
Veröffentlicht 2021Text -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis von Brill, Livnat, Rechtman, Ariel, Zveik, Omri, Haham, Nitzan, Levin, Netta, Shifrin, Alla, Rozenberg, Ayal, Vaknin-Dembinsky, Adi
Veröffentlicht 2022Text -
10
-
11
-
12
Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells von Zveik, Omri, Fainstein, Nina, Rechtman, Ariel, Haham, Nitzan, Ganz, Tal, Lavon, Iris, Brill, Livnat, Vaknin‐Dembinsky, Adi
Veröffentlicht 2022Text -
13
-
14
-
15
Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107 von Mizrachi, Tehila, Marsha, Oshrit, Brusin, Karen, Ben-David, Yael, Thakur, Ganesh A., Vaknin-Dembinsky, Adi, Treinin, Millet, Brenner, Talma
Veröffentlicht 2021Text -
16
Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab von Brill, Livnat, Raposo, Catarina, Rechtman, Ariel, Zveik, Omri, Levin, Netta, Oiknine‐Djian, Esther, Wolf, Dana G., Vaknin‐Dembinsky, Adi
Veröffentlicht 2022Text -
17
Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine() von Brill, Livnat, Rechtman, Ariel, Shifrin, Alla, Rozenberg, Ayal, Afanasiev, Svetlana, Zveik, Omri, Haham, Nitzan, Levin, Neta, Vaknin-Dembinsky, Adi
Veröffentlicht 2022Text -
18
NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness von Mizrachi, Tehila, Brill, Livnat, Rabie, Malcolm, Nevo, Yoram, Fellig, Yakov, Zur, Mayan, Karussis, Dimitrios, Abramsky, Oded, Brenner, Talma, Vaknin-Dembinsky, Adi
Veröffentlicht 2018Text -
19
-
20
Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab von Brill, Livnat, Rechtman, Ariel, Zveik, Omri, Haham, Nitzan, Oiknine-Djian, Esther, Wolf, Dana G., Levin, Netta, Raposo, Catarina, Vaknin-Dembinsky, Adi
Veröffentlicht 2021Text